Effects of vitamin D3 on glucose metabolism in patients with severe osteoarthritis: A randomized double-blind trial comparing daily 2000 with 800 IU vitamin D3
Open Access
- 1 April 2021
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 23 (4), 1011-1019
- https://doi.org/10.1111/dom.14307
Abstract
Aim: To investigate the effect of daily 800 versus 2000 IU of vitamin D3 supplementation over 24 months on glycaemic control in older adults after unilateral knee replacement. Materials and Methods: The Zurich Multiple Endpoint Vitamin D Trial in Knee OA Patients was a randomized, double-blind trial conducted from 2008 to 2014 in Zurich, Switzerland. Participants were randomly allocated to 800 or 2000 IU vitamin D3 daily for 24 months. This study investigates the predefined secondary endpoints of fasting blood glucose (FBG) and homeostatic model assessment for insulin resistance (HOMA-IR) using linear mixed models adjusted for age, sex, baseline vitamin D deficiency and body mass index. Results: A total of 251 participants (age 70.2 +/- 6.5 years; 55.4% women; 39% impaired glucose tolerance, mean 25-hydroxyvitamin D 27.48 +/- 12.48 ng/mL, mean FBG 5.49 +/- 0.71 mmol/L) were included in this analysis. There was no significant difference in FBG between the group receiving 800 versus 2000 IU after 2 years with a least square mean (95% CI) of 5.32 (5.19; 5.44) versus 5.39 (5.27; 5.51) mmol/L (p(treat) = .130) and no difference in HOMA-IR (0.44 [0.37; 0.52] vs. 0.49 [0.41; 0.58]; p(treat) = .162), respectively. However, FBG decreased significantly over time independent of vitamin D3 dose (800 IU: 5.54 [5.42; 5.66] to 5.32 [5.19; 5.44], p(time) < .001; 2000 IU: 5.5 [5.38; 5.62] to 5.39 [5.27; 5.51] mmol/L, p(time) = .019). Conclusions: There was no clinically meaningful difference between 800 and 2000 IU of vitamin D3 over 2 years in FBG or HOMA-IR in community-dwelling older adults. Glycaemic outcomes improved in both groups.Funding Information
- Baugarten Stiftung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00B‐114864)
- Velux Stiftung (Grant Number 441)
This publication has 48 references indexed in Scilit:
- Polymorphisms Related to the Serum 25-Hydroxyvitamin D Level and Risk of Myocardial Infarction, Diabetes, Cancer and Mortality. The Tromsø StudyPLOS ONE, 2012
- Is vitamin D status relevant to metabolic syndrome?Dermato-Endocrinology, 2012
- Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trialThe American Journal of Clinical Nutrition, 2011
- Vitamin D and type 2 diabetes: a systematic reviewEuropean Journal of Clinical Nutrition, 2011
- Daily consumption of vitamin D– or vitamin D + calcium–fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trialThe American Journal of Clinical Nutrition, 2011
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to KnowJournal of Clinical Endocrinology & Metabolism, 2011
- Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 DiabetesDiabetes Care, 2010
- Statistics in Medicine — Reporting of Subgroup Analyses in Clinical TrialsThe New England Journal of Medicine, 2007
- The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2007
- The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic AdultsDiabetes Care, 2007